One might have expected that in a trial (with no run-in apart from demonstrating the ability to take a placebo injection) of a treatment given by injection, at home, every 2 weeks that adherence may have been an issue and that many might have stopped treatment. However, less than 6% stopped treatment per year and this is backed up by the difference in LDL-c between treatment arms which stayed the same over time. Was this expected and do the authors have any comments or advice on how to achieve similar adherence, whether in future trials or in clinical practice?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.